Jerusalem Pharmaceuticals Co. Ltd. reported consolidated earnings results for the first half of 2018. For the period, the company reported sales of USD 16,005,394 compared with USD 17,880,101 a year ago. Net income before tax was USD 2,680,539 compared with USD 3,043,983 a year ago. Net profit after tax of USD 2,680,539 or USD 0.150 basic and diluted earnings per share compared with USD 3,026,907 or USD 0.167 basic and diluted earnings per share a year ago. Net cash flow from operating activities was USD 619,434 compared with net cash used in operating activities of USD 245,795 a year ago. Purchase of property, plant and equipment was USD 393,877 compared with USD 1,050,654 a year ago. Purchase of intangible assets was USD 196,415.